{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:45:01Z","timestamp":1784641501623,"version":"3.55.0"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"19","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81373381"],"award-info":[{"award-number":["81373381"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"crossref","award":["2017ZX09304029"],"award-info":[{"award-number":["2017ZX09304029"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Abstract<\/jats:title>\n            <jats:p>Nephrotic syndrome (NS) can be divided into primary, secondary, and congenital NS 3 types, and primary nephrotic syndrome (PNS) accounts for about 90% of the total number of NS in children, which is a common childhood glomerular disease one. The treatment of children with PNS has been controversial and confused because of hormone tolerance, complications, multiple drug combinations, and other issues, but there are no indicators to assess the rational drug use (RDU) of children with PNS. This study aims to develop a set of indicators to assess the RDU in children with PNS.<\/jats:p>\n            <jats:p>The study is an observational study and the procedure includes 3 steps:<\/jats:p>\n            <jats:p>A consensus was reached after 2 rounds of the Delphi survey and each indicator was weighted. The final indicators included 2 first-rank indicators and 16 second-rank indicators. In round 1, modified 3 indicators, increase 2 indicators and delete 6 indicators. In round 2, reached consensus. The first-rank indicators comprised drug choice (46.96%) and drug usage and dosage (53.04%); The second-rank indicators aimed to the specific drug therapy, including the RDU of hormones, immunomodulators, and adjuvant drug. The score of each indicator met the requirements, therefore, childrens PNS RDU evaluation index system had been established and the index was scientific and credible.<\/jats:p>\n            <jats:p>The first set indicators had been established to assess RDU of children with PNS. Monitoring these indicators will guide people towards the promotion of RDU for PNS. Whats more, the indicator provided a methodological reference for the development of other indicator sets.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000019949","type":"journal-article","created":{"date-parts":[[2020,5,8]],"date-time":"2020-05-08T20:34:08Z","timestamp":1588970048000},"page":"e19949","source":"Crossref","is-referenced-by-count":5,"title":["Application of Delphi method and analytic hierarchy process to establish indicator system for evaluation of rational drug use in children with primary nephrotic syndrome"],"prefix":"10.1097","volume":"99","author":[{"given":"Mao","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Pharmacy"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education (Sichuan University)"},{"name":"West China School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linan","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education (Sichuan University)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education (Sichuan University)"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Tao","sequence":"additional","affiliation":[{"name":"Department of pediatrics, West China Second University Hospital, Sichuan University, Chengdu, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pharmacy"},{"name":"Evidence-Based Pharmacy Center, West China Second University Hospital, Sichuan University"},{"name":"Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education (Sichuan University)"},{"name":"West China School of Pharmacy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,5]]},"reference":[{"key":"R2-20240308","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1056\/NEJMra035092","article-title":"Developmental pharmacology-drug disposition, action, and therapy in infants and children","volume":"349","author":"Kearns","year":"2003","journal-title":"N Engl J Med"},{"key":"R3-20240308","article-title":"Children's medicines: A situational analysis. Campaign \u201cMake medicines child size\u201d. Progress Reports","author":"Finney","year":"2011","journal-title":"Rep Secretariat"},{"key":"R4-20240308","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/jebm.12244","article-title":"Indicators for assessing quality of drug use: a systematic literature review","volume":"10","author":"Song","year":"2017","journal-title":"J Evid Based Med"},{"key":"R5-20240308","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1046\/j.1365-2648.2000.t01-1-01567.x","article-title":"Research guidelines for the Delphi survey technique","volume":"32","author":"Hasson","year":"2000","journal-title":"J Adv Nurs"},{"key":"R6-20240308","doi-asserted-by":"crossref","first-page":"e9308","DOI":"10.1097\/MD.0000000000009308","article-title":"Development of indicators for assessing rational drug use to treat community-acquired pneumonia in children in hospitals and clinics: a modified Delphi study","volume":"96","author":"Li","year":"2017","journal-title":"Medicine"},{"key":"R8-20240308","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2165\/00148581-200810010-00002","article-title":"Cortieostemid resistant nephrotic syndrome with focal and segmental glomerulosclemsis: an update of treatment options for children","volume":"10","author":"Ehfich","year":"2008","journal-title":"Paediatr Drugs"},{"key":"R9-20240308","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","article-title":"Nephrotic syndrome in childhood","volume":"362","author":"Eddy","year":"2003","journal-title":"Lancet"},{"key":"R10-20240308","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00345-016-1932-1","article-title":"Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project","volume":"35","author":"Scheltema","year":"2017","journal-title":"World J Urol"},{"key":"R11-20240308","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s10157-014-1031-9","article-title":"Clinical practice guideline for pediatric idiopathic nephrotic syndrome 2013: general therapy","volume":"19","author":"Kaku","year":"2015","journal-title":"Clin Exp Nephrol"},{"key":"R13-20240308","first-page":"729","article-title":"Children hormone-sensitive, relapse \/dependent nephrotic syndrome diagnosis and treatment guidelines (2016)","volume":"55","year":"2017","journal-title":"Chin Pediatr"},{"key":"R14-20240308","first-page":"167","article-title":"Chinese Medical Association of Pediatrics Nephrology Pediatric kidney disease diagnosis and treatment guidelines (a): hormone-sensitive, relapse\/dependent nephrotic syndrome diagnosis and treatment guidelines (Trial)","volume":"47","author":"Jiang Xiao yun","year":"2009","journal-title":"J Pediatr"},{"key":"R15-20240308","first-page":"72","article-title":"Guidelines for the diagnosis and treatment of common kidney disease in children (Trial) (III): guidelines for the diagnosis and treatment of steroid-resistant nephrotic syndrome","volume":"48","year":"2010","journal-title":"Chin J Pediatr"},{"key":"R16-20240308","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s10157-015-1216-x","article-title":"Evidence-based clinical practice guidelines for nephrotic syndrome 2014","volume":"20","author":"Nishi","year":"2016","journal-title":"Clin Exp Nephrol"},{"key":"R17-20240308","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13052-017-0356-x","article-title":"The Italian Society for Pediatric Nephrology (SINePe) consensus document on the management of nephrotic syndrome in children: part I - diagnosis and treatment of the first episode and the first relapse","volume":"43","author":"Pasini","year":"2017","journal-title":"Ital J Pediatr"},{"key":"R18-20240308","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00467-012-2304-8","article-title":"Treatment of steroid-resistant nephrotic syndrome in children: new guidelines from KDIGO","volume":"28","author":"Lombel","year":"2013","journal-title":"Pediatric Nephrol"},{"key":"R19-20240308","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1053\/j.ajkd.2014.03.003","article-title":"Canadian Society of Nephrology Commentary on the 2012 KDIGO Clinical Practice Guideline for the Management of Blood Pressure in CKD","volume":"63","author":"Ruzicka","year":"2014","journal-title":"American J Kidney Diseases"},{"key":"R20-20240308","first-page":"1","article-title":"A model for priority setting of health technology assessment: the experience of AHP-TOPSIS combination approach","volume":"24","author":"Mohammadreza","year":"2016","journal-title":"DARU"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019949","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,8]],"date-time":"2024-03-08T20:08:55Z","timestamp":1709928535000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000019949"}},"subtitle":["Observational study"],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":17,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000019949","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5]]}}}